SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001102624-15-000250
Filing Date
2015-02-20
Accepted
2015-02-20 10:40:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 BOSTON THERAPEUTICS, INC. SC 13D bostonsc13d.htm SC 13D 232479
  Complete submission text file 0001102624-15-000250.txt   233796
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Subject) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87827 | Film No.: 15634227
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1525 VOORHIES AVENUE BROOKLYN NY 11235
Business Address
Parnes Harold S (Filed by) CIK: 0001634060 (see all company filings)

Type: SC 13D